Data as of 3:56pm ET
| -0.28 / -0.29%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 85.00, with a high estimate of 85.00 and a low estimate of 85.00. The median estimate represents a -12.34% decrease from the last price of 96.97.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.